Improving Cardiac Resynchronisation Therapy
نویسندگان
چکیده
منابع مشابه
Age of cardiac resynchronisation therapy; cardiac resynchronisation therapy in elderly
I have read the article entitled “Is cardiac resynchronisation therapy feasible, safe and beneficial in the very elderly?” by Olechowski, et al. with great interest, recently published in Journal of Geriatric Cardiology. The investigators reported that implantation of cardiac resynchronisation therapy (CRT) is feasible and safe in very elderly despite extensive co-morbidity. I would like to emp...
متن کاملIs Cardiac Resynchronisation Therapy Proarrhythmic?
It is well established that cardiac resynchronisation therapy (CRT) using biventricular pacing prolongs survival by its effects on pump failure. The rate of sudden cardiac death in patients undergoing CRT, however, remains high. Animal and human studies have shown that reversal of normal sequence of myocardial activation during epicardial pacing, as applied during CRT, increases the transmural ...
متن کاملCurrent aspects of cardiac resynchronisation therapy
ent using echocardiographic parameters, CRT was harmful in those patients with narrow QRS complexes [8]. In more than 20 years of experience with CRT-related issues, we have deepened our knowledge about indication, implantation, evaluation, and optimisation of CRT. With the rapid development of the CRT technology new challenges arise. This special issue of the Netherlands Heart Journal elucidat...
متن کاملEchocardiographic changes after cardiac resynchronisation therapy.
BACKGROUND AND AIM The aim of this prospective study was to evaluate echocardiographic changes in clinical responders and nonresponders after 3 and 15 months of cardiac resynchronisation therapy (CRT). METHODS Fifty eight patients in whom a biventricular system was implanted between 2005 and 2008 were followed up at 3 and at 15 months. Clinical and echocardiography parameters including intra-...
متن کاملCardiac resynchronisation therapy is cost effective.
Conflicts of interests: Drs Freemantle and Cleland were members of the CARE-HF trial Steering Committee funded by Medtronic. All authors received funding to attend meetings and undertake work relating to the trial and authored the cost-effectiveness analyses. All authors have received honoraria for speaking at meetings and research funding from companies in the pharmaceutical and device industr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Arrhythmia & Electrophysiology Review
سال: 2019
ISSN: 2050-3369,2050-3377
DOI: 10.15420/aer.2018.62.3